Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical...
Background: FAP radiopharmaceuticals show promise for cancer diagnosis; however, their limited tumor residency hinders treatment. This study compared two FAPi derivatives, DOTA.SA.FAPi and DOTAGA.(...
mdpi.com